LAP Group
Status
Current
Country
Germany
Strategy
Mid Cap
Sector
Entry
Jul-19
Fund
IK VIII
Website
News
Leading provider of laser projection, measurement and machine vision systems for the Healthcare and Industrial segments
Founded in 1984 and headquartered in Lüneburg, Germany, LAP Group (“LAP” or “the Group”) is a leading provider of integrated laser projection, in-line measurement and machine vision systems for end-markets such as radiotherapy and manufacturing.
LAP offers full coverage of the radiotherapy workflow and in 2024 entered the camera-based patient positioning market by launching surface guided radiotherapy (“SGRT”) – a system providing an integrated, high-precision patient positioning workflow. The Group also supplies premium machine vision solutions and versatile in-line measurement equipment to the manufacturing industries. The Group has 300 employees across seven offices in Europe, America and Asia, who serve more than 9,000 customers globally.
IK Partners acquired the investment from capiton in July 2019.
What Attracted Us to the Business
- Optimised go-to-market model with direct access to manufacturers, distributors and end-customers
- Highly efficient, assembly-focused operations with strong organisational structure
- Well positioned to drive organic and inorganic growth
- Focus on attractive and diversified end markets driven by strong trends
Our Value Creation Strategy
We are working alongside management to:
- Scale the SGRT business through leveraging LAP’s strong reputation, OEM partnerships and unique software capabilities;
- Drive further consolidation in the radiotherapy and industrial markets through a targeted M&A strategy;
- Explore expansion into underrepresented geographies and new end-markets; and
- Undertake service transformation to improve commercialisation of services and unlock recurring revenue potentials.
Quote from LAP Group
“With our high precision and easy to use measurement and projection systems, LAP has formed long-standing relationships with our global radiotherapy and industrial blue-chip customers. IK is a great partner as they have a genuine understanding of the medical technology as well as our various other end-markets and share our growth strategy.”
Thomas Simmerer, Chief Executive Officer
